louisiana glp-1 intestinal paralysis class action Lawsuit against makers of Ozempic, Mounjaro claims meds caused 'stomach paralysis' louisiana semaglutide gastrointestinal obstruction class

doi: 10.1210/jc.2014-3415 [DOI] [PubMed] [Google Scholar] 35.Karagiannis T., et al., Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis

Full article here: To view or add a comment, sign in Around the world, millions of people who live with #obesity are at the point in their weight loss journey where, after successfully accessing and using prescription weight loss medications such as Wegovy or Mounjaro and having reached their initial weight loss goal, ask: what's next

They go get their treatment

This increase in fundic mucosal GLP-1 following RYGB but not VSG was consistent in diet-induced obese rats, where instead, VSG surgery induced a 50% increase in GLP-1+ cells in the antrum (Ribeiro-Parenti et al., 2021)